Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer

被引:269
作者
Ono, Makiko [2 ,7 ]
Tsuda, Hitoshi [1 ]
Shimizu, Chikako [2 ]
Yamamoto, Sohei [3 ]
Shibata, Tatsuhiro [4 ]
Yamamoto, Harukaze [2 ]
Hirata, Taizo [2 ]
Yonemori, Kan [2 ]
Ando, Masashi [2 ]
Tamura, Kenji [2 ]
Katsumata, Noriyuki [2 ]
Kinoshita, Takayuki [5 ]
Takiguchi, Yuichi [6 ]
Tanzawa, Hideki [7 ]
Fujiwara, Yasuhiro [2 ]
机构
[1] Natl Canc Ctr, Dept Pathol, Clin Lab Div, Chuo Ku, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Breast & Med Oncol Div, Chuo Ku, Tokyo 1040045, Japan
[3] Natl Def Med Coll, Dept Basic Pathol, Tokorozawa, Saitama 3598513, Japan
[4] Ctr Res Inst, Ctr Med Gen, Div Pathol, Canc Genom Project,Chuo Ku, Tokyo 1040045, Japan
[5] Natl Canc Ctr, Breast Surg Div, Chuo Ku, Tokyo 1040045, Japan
[6] Chiba Univ, Grad Sch Med, Dept Respirol, Chuo Ku, Chiba 2608670, Japan
[7] Chiba Univ, Dept Clin Mol Biol, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan
关键词
Triple-negative breast cancer; Neoadjuvant chemotherapy; Pathological complete response; Tumor-infiltrating lymphocytes; Tumor cell apoptosis; PROGNOSTIC-SIGNIFICANCE; EXPRESSION; SUBTYPES; CARCINOMA; PATTERNS; DOCETAXEL; SURVIVAL; FEATURES;
D O I
10.1007/s10549-011-1554-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of the present study was to identify histological surrogate predictive markers of pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC). Among 474 patients who received NAC and subsequent surgical therapy for stage II-III invasive breast carcinoma between 1999 and 2007, 102 (22%) had TNBC, and 92 core needle biopsy (CNB) specimens obtained before NAC were available. As controls, CNB specimens from 42 tumors of the hormone receptor-negative and HER2-positive (HR-/HER2+) subtype and 46 tumors of the hormone receptor-positive and HER2-negative (HR+/HER2-) subtype were also included. Histopathological examination including tumor-infiltrating lymphocytes (TIL) and tumor cell apoptosis, and immunohistochemical studies for basal markers were performed, and the correlation of these data with pathological therapeutic effect was analyzed. The rates of pCR at the primary site were higher for TNBC (32%) and the HR-/HER2+ subtype (21%) than for the HR+/HER2- subtype (7%) (P = 0.006). Expression of basal markers and p53, histological grade 3, high TIL scores, and apoptosis were more frequent in TNBC and the HR-/HER2+ subtype than in the HR+/HER2- subtype (P = 0.002 for TIL and P < 0.001 for others). In TNBC, the pCR rates of tumors showing a high TIL score and of those showing a high apoptosis score were 37 and 47%, respectively, and significantly higher or tended to be higher than those of the tumors showing a low TIL score and of the tumors showing a low apoptosis score (16 and 27%, respectively, P = 0.05 and 0.10). In a total of 180 breast cancers, the pCR rates of the tumors showing a high TIL score (34%) and of those showing a high apoptosis score (35%) were significantly higher than those of the tumors showing a low TIL score (10%) and those of the tumors showing a low apoptosis score (19%) (P = 0.0001 and 0.04, respectively). Histological grade and basal marker expression were not correlated with pCR. Although the whole analysis was exploratory, the degree of TIL correlated with immune response appear to play a substantial role in the response to NAC in TNBC.
引用
收藏
页码:793 / 805
页数:13
相关论文
共 38 条
[1]  
Allred DC, 1998, MODERN PATHOL, V11, P155
[2]   Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy [J].
Apetoh, Lionel ;
Ghiringhelli, Francois ;
Tesniere, Antoine ;
Obeid, Michel ;
Ortiz, Carla ;
Criollo, Alfredo ;
Mignot, Gregoire ;
Maiuri, M. Chiara ;
Ullrich, Evelyn ;
Saulnier, Patrick ;
Yang, Huan ;
Amigorena, Sebastian ;
Ryffel, Bernard ;
Barrat, Franck J. ;
Saftig, Paul ;
Levi, Francis ;
Lidereau, Rosette ;
Nogues, Catherine ;
Mira, Jean-Paul ;
Chompret, Agnes ;
Joulin, Virginie ;
Clavel-Chapelon, Francoise ;
Bourhis, Jean ;
Andre, Fabrice ;
Delaloge, Suzette ;
Tursz, Thomas ;
Kroemer, Guido ;
Zitvogel, Laurence .
NATURE MEDICINE, 2007, 13 (09) :1050-1059
[3]   p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes [J].
Bidard, F. -C. ;
Matthieu, M. -C. ;
Chollet, P. ;
Raoefils, I. ;
Abrial, C. ;
Domont, J. ;
Spielmann, M. ;
Delaloge, S. ;
Andre, F. ;
Penault-Llorca, F. .
ANNALS OF ONCOLOGY, 2008, 19 (07) :1261-1265
[4]   The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes [J].
Carey, Lisa A. ;
Dees, E. Claire ;
Sawyer, Lynda ;
Gatti, Lisa ;
Moore, Dominic T. ;
Collichio, Frances ;
Ollila, David W. ;
Sartor, Carolyn I. ;
Graham, Mark L. ;
Perou, Charles M. .
CLINICAL CANCER RESEARCH, 2007, 13 (08) :2329-2334
[5]   Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study [J].
Carey, Lisa A. ;
Perou, Charles M. ;
Livasy, Chad A. ;
Dressler, Lynn G. ;
Cowan, David ;
Conway, Kathleen ;
Karaca, Gamze ;
Troester, Melissa A. ;
Tse, Chiu Kit ;
Edmiston, Sharon ;
Deming, Sandra L. ;
Geradts, Joseph ;
Cheang, Maggie C. U. ;
Nielsen, Torsten O. ;
Moorman, Patricia G. ;
Earp, H. Shelton ;
Millikan, Robert C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2492-2502
[6]  
CARLOMAGNO C, 1995, ONCOLOGY-BASEL, V52, P272
[7]   Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype [J].
Cheang, Maggie C. U. ;
Voduc, David ;
Bajdik, Chris ;
Leung, Samuel ;
McKinney, Steven ;
Chia, Stephen K. ;
Perou, Charles M. ;
Nielsen, Torsten O. .
CLINICAL CANCER RESEARCH, 2008, 14 (05) :1368-1376
[8]  
Demaria S, 2001, CLIN CANCER RES, V7, P3025
[9]   Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer [J].
Denkert, Carsten ;
Loibl, Sibylle ;
Noske, Aurelia ;
Roller, Marc ;
Mueller, Berit Maria ;
Komor, Martina ;
Budczies, Jan ;
Darb-Esfahani, Silvia ;
Kronenwett, Ralf ;
Hanusch, Claus ;
von Toerne, Christian ;
Weichert, Wilko ;
Engels, Knut ;
Solbach, Christine ;
Schrader, Iris ;
Dietel, Manfred ;
von Minckwitz, Gunter .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :105-113
[10]   Triple-negative breast cancer: Clinical features and patterns of recurrence [J].
Dent, Rebecca ;
Trudeau, Maureen ;
Pritchard, Kathleen I. ;
Hanna, Wedad M. ;
Kahn, Harriet K. ;
Sawka, Carol A. ;
Lickley, Lavina A. ;
Rawlinson, Ellen ;
Sun, Ping ;
Narod, Steven A. .
CLINICAL CANCER RESEARCH, 2007, 13 (15) :4429-4434